Enliven Therapeutics
ELVN
ELVN
32 hedge funds and large institutions have $228M invested in Enliven Therapeutics in 2020 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 8 increasing their positions, 16 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
32
Holders Change
-2
Holders Change %
-5.88%
% of All Funds
0.65%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
2
Increased
8
Reduced
16
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
SO
26
STRS Ohio
Columbus,
Ohio
| $26K | – | – | – |
|
27
Morgan Stanley
New York
| $19K | -$81K | -1,006 | -81% |
|
28
Legal & General Group
London,
United Kingdom
| $13K | -$4K | -48 | -24% |
|
|
AIP
29
Ameritas Investment Partners
Lincoln,
Nebraska
| $9K | – | – | – |
|
30
Citigroup
New York
| $5K | -$9K | -108 | -64% |
|
31
Bank of Montreal
Toronto,
Ontario, Canada
| $4K | -$2.95K | -42 | -42% |
|
32
Jane Street
New York
| – | -$314K | -2,835 | Closed |
|
33
Millennium Management
New York
| – | -$306K | -2,768 | Closed |
|
34
Nuveen Asset Management
Chicago,
Illinois
| – | -$220K | -1,989 | Closed |
|
35
UBS Group
Zurich,
Switzerland
| – | -$43K | -391 | Closed |
|